FDA appoints biotech veteran George Tidmarsh as new CDER director
TL;DR Summary
George Tidmarsh, a Stanford faculty member with extensive experience in drug development and clinical medicine, has been appointed as the new Director of the FDA's Center for Drug Evaluation and Research, where he will oversee efforts to ensure the safety and efficacy of drugs in the U.S.
Topics:business#center-for-drug-evaluation-and-research#drug-development#fda#george-tidmarsh#health#regulatory-science
- Stanford faculty member George Tidmarsh, M.D., Ph.D. named Director of Center for Drug Evaluation and Research fda.gov
- FDA taps biotech industry veteran as RFK Jr.'s top drug regulator CNBC
- FDA names former pharmaceutical company executive to oversee US drug program AP News
- FDA Appoints Biotech Executive as Top Drug Regulator Under RFK Jr. Los Angeles Times
- FDA names next CDER director in biotech vet George Tidmarsh Fierce Pharma
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 2 min read
Condensed
88%
380 → 47 words
Want the full story? Read the original article
Read on fda.gov